The prostaglandin E-2 and F-2 alpha receptor genes are expressed in human myometrium and are down-regulated during pregnancy

被引:67
作者
Matsumoto, T [1 ]
Sagawa, N [1 ]
Yoshida, M [1 ]
Mori, T [1 ]
Tanaka, I [1 ]
Mukoyama, M [1 ]
Kotani, M [1 ]
Nakao, K [1 ]
机构
[1] KYOTO UNIV,GRAD SCH MED,DEPT MED & CLIN SCI,KYOTO 606,JAPAN
关键词
D O I
10.1006/bbrc.1997.7397
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostaglandin (PG) E-2 and PGF(2 alpha) are believed to play important roles in the myometrial contraction and the initiation of labor. Myometrial contraction by these prostanoids is mediated mainly through EP3 and FP, which are specific receptors to PGE(2) and PGF(2 alpha), respectively. During normal pregnancy, uterine myometrium are relaxed until term. To explore the involvement of EP3 and FP in the myometrial relaxation during pregnancy, we examined the EP3 and FP gene expressions in nonpregnant and pregnant myometrium obtained by hysterectomy for gynecological diseases. In all samples examined, expressions of EP3 and FP genes were detected. During pregnancy, the expression of EP3 gene In human myometrium was significantly reduced, to 60% of that in nonpregnant myometrium. The expression of FP gene in human myometrium also decreased during pregnancy to 55% of that in nonpregnant myometrium. In the myometrium from the nonpregnant women taking combined oral contraceptives, the gene expressions of EP3 and FP were not significantly changed as compared to those in nonpregnant controls. The down-regulation of EP3 and FP during pregnancy may play a role in the relaxation of myometrium and thus in the maintenance of normal pregnancy in humans. (C) 1997 Academic Press.
引用
收藏
页码:838 / 841
页数:4
相关论文
共 17 条
[1]  
ABRAMOVITZ M, 1994, J BIOL CHEM, V269, P2632
[2]  
[Anonymous], BIOL UTERUS
[3]   INVOLVEMENT OF A NITRIC OXIDE-CYCLIC GUANOSINE-MONOPHOSPHATE PATHWAY IN CONTROL OF HUMAN UTERINE CONTRACTILITY DURING PREGNANCY [J].
BUHIMSCHI, I ;
YALLAMPALLI, C ;
DONG, YL ;
GARFIELD, RE .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (05) :1577-1584
[4]   A NOVEL INHIBITORY PROSTANOID RECEPTOR IN PIGLET SAPHENOUS-VEIN [J].
COLEMAN, RA ;
GRIX, SP ;
HEAD, SA ;
LOUTTIT, JB ;
MALLETT, A ;
SHELDRICK, RLG .
PROSTAGLANDINS, 1994, 47 (02) :151-168
[5]  
COLEMAN RA, 1990, COMPREHENSIVE MED CH, V3, P643
[6]   PROSTAGLANDIN-E AND PROSTAGLANDIN-F-2ALPHA RECEPTORS IN HUMAN MYOMETRIUM DURING THE MENSTRUAL-CYCLE AND IN PREGNANCY AND LABOR [J].
GIANNOPOULOS, G ;
JACKSON, K ;
KREDENTSER, J ;
TULCHINSKY, D .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 153 (08) :904-910
[7]   OXYTOCIN RELEASE BY INFUSED PROSTAGLANDIN [J].
GILLESPIE, A ;
CHARD, T ;
BRUMMER, HC .
BMJ-BRITISH MEDICAL JOURNAL, 1972, 1 (5799) :543-+
[8]   EXPRESSION OF BIOLOGICALLY-ACTIVE RECEPTORS FOR NATRIURETIC PEPTIDES IN THE HUMAN UTERUS DURING PREGNANCY [J].
ITOH, H ;
SAGAWA, N ;
HASEGAWA, M ;
NANNO, H ;
KOBAYASHI, F ;
IHARA, Y ;
MORI, T ;
KOMATSU, Y ;
SUGA, SI ;
YOSHIMASA, T ;
ITOH, H ;
NAKAO, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (01) :602-607
[9]  
KOTANI M, 1995, MOL PHARMACOL, V48, P869
[10]  
Liggins G C, 1973, Recent Prog Horm Res, V29, P111